Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma oscillations are patterns of synchronized electrical activity between populations of neurons in the brain, manifesting in frequency bands of approximately 30–90 Hz (sometimes extended up to 150 Hz). They are considered crucial for coordination between brain areas, perception, attention, working memory, and other cognitive and behavioral processes. Their disruption is associated with a range of neuropsychiatric and neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, schizophrenia, epilepsy, and Fragile X syndrome. Gamma oscillations are generated by synchronized firing of neuronal groups, particularly involving inhibitory interneurons. While not a traditional “therapeutic target,” emerging research explores non-invasive strategies (like sensory or electrical stimulation at gamma frequencies) to restore gamma activity as a possible treatment for cognitive dysfunction in disorders such as Alzheimer’s disease.
Non-pharmacological mechanisms include neural entrainment via sensory stimulation or brain stimulation techniques at gamma frequencies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma oscillation.